Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary

被引：0
|
作者：
Abou-Taleb, H. [1 ]
Yamaguchi, K. [1 ]
Mandai, M. [1 ]
Amano, Y. [1 ]
Kosaka, K. [1 ]
Matsumura, N. [1 ]
Baba, T. [1 ]
Yoshioka, Y. [1 ]
Hamanishi, J. [1 ]
Konishi, I [1 ]
机构：
[1] Kyoto Univ Shogoin, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, Kyoto, Japan
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2012年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [31] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Ge, Huijuan
    Xiao, Yaoxin
    Qin, Guangqi
    Gu, Yanzi
    Cai, Xu
    Jiang, Wenhua
    Tu, Xiaoyu
    Yang, Wentao
    Bi, Rui
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [32] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Huijuan Ge
    Yaoxin Xiao
    Guangqi Qin
    Yanzi Gu
    Xu Cai
    Wenhua Jiang
    Xiaoyu Tu
    Wentao Yang
    Rui Bi
    Diagnostic Pathology, 16
  • [33] Distinct roles of HNF1β, HNF1α, and HNF4α in regulating pancreas development, β-cell function and growth
    Maestro, Miguel Angel
    Cardalcla, Carina
    Boj, Sylvia F.
    Luco, Reini F.
    Servitja, Joan Marc
    Ferrer, Jorge
    DEVELOPMENT OF THE PANCREAS AND NEONATAL DIABETES, 2007, 12 : 33 - 45
  • [34] Evidence Supporting Endometriosis as a Precursor of Ovarian Clear Cell and Endometrioid Carcinoma Based on Expression of ARID1A
    Ayhan, A.
    Mao, T-L
    Wu, C-H
    Ogawa, H.
    Futagami, M.
    Mizukami, H.
    Yokoyama, Y.
    Kurman, R. J.
    Shih, I-M
    LABORATORY INVESTIGATION, 2012, 92 : 259A - 259A
  • [35] Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations
    Bitler, Benjamin G.
    Aird, Katherine M.
    Zhang, Rugang
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (01):
  • [36] Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma
    Stewart, J. R.
    Baxter, J.
    Zatreanu, D.
    Brough, R.
    Song, F.
    Konde, A.
    Krastev, D.
    Alexander, J.
    Natrajan, R.
    Pettitt, S.
    Banerjee, S.
    Lord, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S383 - S384
  • [37] Evidence Supporting Endometriosis as a Precursor of Ovarian Clear Cell and Endometrioid Carcinoma Based on Expression of ARID1A
    Ayhan, A.
    Mao, T-L
    Wu, C-H
    Ogawa, H.
    Futagami, M.
    Mizukami, H.
    Yokoyama, Y.
    Kurman, R. J.
    Shih, I-M
    MODERN PATHOLOGY, 2012, 25 : 259A - 259A
  • [38] Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma
    Li, Shang
    Meersma, Gert Jan
    Kupryjanczyk, Jolanta
    de Jong, Steven
    Wisman, G. Bea A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [39] HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
    Lopes-Coelho, Filipa
    Gouveia-Fernandes, Sofia
    Goncalves, Luis G.
    Nunes, Carolina
    Faustino, Ines
    Silva, Fernanda
    Felix, Ana
    Pereira, Sofia A.
    Serpa, Jacinta
    TUMOR BIOLOGY, 2016, 37 (04) : 4813 - 4829
  • [40] HDAC6 AS A THERAPEUTIC TARGET FOR OVARIAN CLEAR CELL CARCINOMA, IN ASSOCIATION WITH ARID1A LOSS
    Yano, M.
    Yasuda, M.
    Miyazawa, M.
    Miwa, M.
    Hasegawa, K.
    Narahara, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 874 - 874
12345